CBAM 494/2025 JANSSEN CILAG/08
Sector: Hospital • Location: Spain
Source: TED Europa
PNAMSP 126/2025 ACUERDO MARCO UNA ÚNICA EMPRESA POR EL QUE SE FIJAN CONDICIONES PARA SUM.TRACTO SUCESIVO Y PRECIO U. DEL MEDICAMENTO EXCLUSIVO CILTACABTAGEN AUTOLEUCEL 3,20MILL CELULAS/INYECTABLE IV 30 ML-Capac:30;Forma farmacéutica INYECTABLE IV(DENOMINACIÓN COMERCIAL CARVYKTI 3,2×10 6-1×108 CELULAS DISPERSION PARA PERFUSION),PARA HOSP.U.VIRG.ROCÍO,REINA SOFÍA Y REGIONAL,CENTROS ADSCRITOS A CPC D
- Status
- Closed
- Sector
- Hospital, Commercial
- Location
- Spain
- Updated
- 3 Nov 2026
- Source
- TED Europa
ConstructChat
Ask ConstructChat about CBAM 494/2025 JANSSEN CILAG/08
Pick a question to edit it, or write your own.
First answer free · no account
Tender Information FAQ
Tender Information
Participants
| Not available for this record. |
Status
Original status | contract award notice |
Taiyo status | Closed |
Taiyo last update | 2026-11-03 |
Contact
| Not available for this record. |
Description
Description | PNAMSP 126/2025 ACUERDO MARCO UNA ÚNICA EMPRESA POR EL QUE SE FIJAN CONDICIONES PARA SUM.TRACTO SUCESIVO Y PRECIO U. DEL MEDICAMENTO EXCLUSIVO CILTACABTAGEN AUTOLEUCEL 3,20MILL CELULAS/INYECTABLE IV 30 ML-Capac:30;Forma farmacéutica INYECTABLE IV(DENOMINACIÓN COMERCIAL CARVYKTI 3,2×10 6-1×108 CELULAS DISPERSION PARA PERFUSION),PARA HOSP.U.VIRG.ROCÍO,REINA SOFÍA Y REGIONAL,CENTROS ADSCRITOS A CPC DE SEVILLA,CÓRDOBA Y MÁLAGA,MEDIANTE PROC.NEG.SIN PUBLIC.CON EMPRESA JANSSEN-CILAG,SA,TRAMITE URGENTE |
Original sector | Medical equipments, pharmaceuticals and personal care products |
Budget |
Location
Country | Spain |
Source
Source | TED Europa |
URL |
More Details
Record type | Tender |
Sector | Hospital, Commercial |
Article published date | 2026-10-27 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this tender
- News and media coverage
- Technical research
Free account · no card · lands you back on this tender